author-photo

Viviane Brel

University of Rennes

26

Papers

237

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 6425: Sensitivity of oncogenic KRAS-expressing cells to CDK9 inhibition identified by a phenotypic compound screen

2020
Show All
- Source
- Cite
- Save
Citations (0)
Partial synthesis of 14-deoxy-14-aminotriptolide

2016 Tetrahedron Letters
Show All
- Source
- Cite
- Save
Citations (4)
A functional procedure using fresh samples to select patients with acute myeloid leukemia prior to treatment with the novel targeted cytotoxic agent F14512

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 988: F14512, a novel vectorized topoiserase II inhibitor, bypasses MDR1 mediated resistance.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity

2013 Leukemia
Show All
- Source
- Cite
- Save
Citations (28)
Abstract 2747: Synergistic antileukemic activity of F14512 in combination with AraC

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
925 F14512, a Polyamine Vectorized Anti-cancer Drug Exhibits a Marked Antileukemic Activity, Alone and in Combination With AraC

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Semisynthetic neoboutomellerone derivatives as ubiquitin-proteasome pathway inhibitors

2012 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (4)
Abstract 1925: Trifluoromethylated artemisinin dimers demonstrate a potent anti-cancer activity in vitro and in vivo

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)